Blog Archives

Researchers develop Potential New Treatment Approach for Breast Cancer

  Irish cancer researchers have developed a potential new treatment approach for a form of breast cancer, which can be difficult to treat. The Opens in new windowBREAST-PREDICT researchers at RCSI focused on a form of cancer that affects around one in eight breast cancer patients. The type of cancer targeted – invasive lobular breast cancer – […]

Read More

Irish Team to Investigate Metatastic Breast Cancer

Dublin-based scientists have been awarded funding to investigate how breast cancer tumours spread to the brain. Almost 2,800 women are newly diagnosed with breast cancer every year in Ireland, and while survival rates have increased, if the breast tumours begin to spread to other parts of the body, which is known as secondary or metastatic […]

Read More

Irish Researchers Find Vitamin D Link to Breast Cancer Survival

Brian Hutton for The Irish Times Breast cancer patients taking vitamin D supplements after being diagnosed were found to have better survival rates, a study of thousands of Irish women by cancer researchers has found. Both the Royal College of Surgeons in Ireland (RCSI), which led the research, and the Irish Cancer Society (ICS) say […]

Read More

Irish Scientists Make Major Breakthrough in Breast Cancer Research

Potential drug identified by NUIG team that reduces cancer and helps improve treatment Kevin O’Sullivan Irish scientists have identified why there is a high relapse rate after chemotherapy in women who have the most aggressive form of breast cancer. The breakthrough has enabled the researchers at NUI Galway to develop a drug with potential for clinical use, […]

Read More

Breakthrough Allows Identification of Resistance to Breast Cancer Treatment

Early detection development by Irish researchers enables different strategy to be put in place Kevin O’Sullivan   Irish researchers have developed a way of identifying women with breast cancer who are likely to be “resistant” to some of the most common treatments for the disease. Their breakthrough comes with the potential to identify such patients […]

Read More

QUB and Almac Group in New Breast Cancer Discovery

Almac Group’s Diagnostics business, in collaboration with Queen’s University, has announced the identification of a novel immune response mechanism in breast tumours deficient in DNA repair. The study has been published in the Journal of the National Cancer Institute (JNCI). The publication entitled ‘Activation of STING-Dependent Innate Immune Signalling By S-Phase-Specific DNA Damage in Breast […]

Read More

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close